Natarajan Sethuraman, Ph.D., serves as the Chief Scientific Officer at Entrada Therapeutics Inc., a position he has held since joining the company. Dr. Sethuraman is a distinguished scientist with a robust background in biotechnology and pharmaceuticals, particularly in the fields of protein engineering and drug development. He earned his Ph.D. in Biochemistry from the University of Georgia and has since built a career marked by significant contributions to the advancement of therapeutic technologies. Before joining Entrada Therapeutics, Dr. Sethuraman held key leadership roles at several prominent biotech firms. He was instrumental in the development of novel therapeutic platforms at companies such as Biogen and Momenta Pharmaceuticals, where he led research teams focused on creating innovative treatments for various diseases. His work has resulted in numerous patents and publications, underscoring his impact on the field. At Entrada Therapeutics, Dr. Sethuraman oversees the scientific strategy and leads the research and development efforts to harness the company's proprietary intracellular biologics platform. His leadership is pivotal in driving the company's mission to develop transformative therapies for patients with unmet medical needs.